257 related articles for article (PubMed ID: 15462607)
1. Human genetics and responses to influenza vaccination: clinical implications.
Lambkin R; Novelli P; Oxford J; Gelder C
Am J Pharmacogenomics; 2004; 4(5):293-8. PubMed ID: 15462607
[TBL] [Abstract][Full Text] [Related]
2. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
[TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
4. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
J Virol; 2017 May; 91(9):. PubMed ID: 28179535
[TBL] [Abstract][Full Text] [Related]
5. Associations between human leukocyte antigens and nonresponsiveness to influenza vaccine.
Gelder CM; Lambkin R; Hart KW; Fleming D; Williams OM; Bunce M; Welsh KI; Marshall SE; Oxford J
J Infect Dis; 2002 Jan; 185(1):114-7. PubMed ID: 11756990
[TBL] [Abstract][Full Text] [Related]
6. The road to a more effective influenza vaccine: Up to date studies and future prospects.
Sano K; Ainai A; Suzuki T; Hasegawa H
Vaccine; 2017 Sep; 35(40):5388-5395. PubMed ID: 28866292
[TBL] [Abstract][Full Text] [Related]
7. Seasonal influenza vaccines.
Fiore AE; Bridges CB; Cox NJ
Curr Top Microbiol Immunol; 2009; 333():43-82. PubMed ID: 19768400
[TBL] [Abstract][Full Text] [Related]
8. Novel Platforms for the Development of a Universal Influenza Vaccine.
Kumar A; Meldgaard TS; Bertholet S
Front Immunol; 2018; 9():600. PubMed ID: 29628926
[TBL] [Abstract][Full Text] [Related]
9. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
[TBL] [Abstract][Full Text] [Related]
10. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
11. Hemagglutinin-specific CD4
Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
Walz L; Kays SK; Zimmer G; von Messling V
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
[TBL] [Abstract][Full Text] [Related]
13. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
[TBL] [Abstract][Full Text] [Related]
14. Correlation between human leukocyte antigen class II alleles and HAI titers detected post-influenza vaccination.
Moss AJ; Gaughran FP; Karasu A; Gilbert AS; Mann AJ; Gelder CM; Oxford JS; Stephens HA; Lambkin-Williams R
PLoS One; 2013; 8(8):e71376. PubMed ID: 23951151
[TBL] [Abstract][Full Text] [Related]
15. Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination.
McDermott AB; Zuckerman JN; Sabin CA; Marsh SG; Madrigal JA
Tissue Antigens; 1997 Jul; 50(1):8-14. PubMed ID: 9243749
[TBL] [Abstract][Full Text] [Related]
16. Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection.
Gelder CM; Welsh KI; Faith A; Lamb JR; Askonas BA
J Virol; 1995 Dec; 69(12):7497-506. PubMed ID: 7494256
[TBL] [Abstract][Full Text] [Related]
17. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
Johansson BE; Kilbourne ED
Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
[TBL] [Abstract][Full Text] [Related]
18. Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.
Garner-Spitzer E; Wagner A; Paulke-Korinek M; Kollaritsch H; Heinz FX; Redlberger-Fritz M; Stiasny K; Fischer GF; Kundi M; Wiedermann U
J Immunol; 2013 Sep; 191(5):2426-36. PubMed ID: 23872054
[TBL] [Abstract][Full Text] [Related]
19. A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.
Andersen TK; Zhou F; Cox R; Bogen B; Grødeland G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931687
[TBL] [Abstract][Full Text] [Related]
20. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection.
DeDiego ML; Anderson CS; Yang H; Holden-Wiltse J; Fitzgerald T; Treanor JJ; Topham DJ
Immunology; 2016 Jun; 148(2):160-73. PubMed ID: 26854888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
